As the business potential of smart healthcare continues to rise, not only is Quanta accelerating its efforts, but major ODM players including Compal Electronics, Inventec, and Wistron are also actively advancing their smart healthcare strategies, each aiming to build long-term strength in the sector.

Compal is heavily investing in smart healthcare and expanding its footprint in the health industry. The company broke ground on its new long-term care facility in Ruifang at the end of last year, with a total investment of nearly NT$1 billion. Scheduled for completion and operation by 2028, the facility will serve as a key hub for Compal’s development in smart healthcare, telemedicine, precision medicine, and preventive care. It will incorporate medical AI and AIoT technologies.

Compal currently has multiple smart healthcare projects underway in collaboration with several major medical institutions in Taiwan and has established strategic partnerships in the field.

Inventec Group Chairman Yeh Kuo-I made a notable appearance at the Healthcare+ Expo Taiwan last year, underscoring the group’s commitment to its healthcare business. Yeh emphasized that Inventec’s healthcare division has already seen promising results. The group’s smart infusion system, developed by subsidiary Invax, has been adopted by both National Taiwan University Hospital and Taipei Medical University Hospital, and has also entered healthcare systems overseas. The group’s smart healthcare efforts are beginning to bear fruit, with ambitions to expand beyond Southeast Asia to the global market.

Another key product, InnoCare’s AI-powered wound management software, obtained regulatory approval and successfully launched commercially within six months. This year, it has been implemented at Shin Kong Hospital, helping to digitize, automate, and streamline the hospital’s wound care workflow. A memorandum of understanding for further cooperation between the two parties is also on the horizon, aiming to boost momentum in smart healthcare initiatives.

Wistron, through its subsidiary Wistron Medical, is also entering the smart healthcare space. In March, it announced a partnership with Taipei Medical University to conduct clinical trials within TMU’s affiliated hospitals. The trials focus on health monitoring for hemodialysis patients, using Wistron Medical’s self-developed BestShape VS device to continuously monitor patients’ physiological data during dialysis, laying the groundwork for the development of AI-based predictive models.

Resource: 仁寶、英業達、緯創 進場智慧醫療卡位